Marken Releases Results Of Industry Survey
Company Noted for Quality and On Time Delivery
Marken announced recently the completion of an industry wide, independent market research study. The survey included 250 key decision makers of clinical trial logistics services from pharmaceutical companies, central laboratories, clinical research organizations and manufacturing service providers in North America, Central & South America, Europe, and Asia. Key topics profiled in the survey included market trends, industry pain points and selection criteria for logistics providers.
Respondents indicated that 64% of supply chain executives plan to increase their expenditure in clinical trial logistics in the next two years. The nature and complexity of new drugs and their protocols entering clinical development will increase their use of dedicated supply chain providers in the space. Temperature control capabilities (57%) and guaranteed on time delivery within specifications (53%) as well as real time traceability of shipments (49%) were the dominant reasons for companies moving to specialty providers such as Marken. More than 50% reported that their organization had moved their clinical trials logistics business to a dedicated supply chain provider such as Marken within the previous 24 months.
Wes Wheeler, Chief Executive Officer of Marken, commented, “An increasing focus on rare diseases requires the industry to recruit patients from a larger pool of countries across the globe. The increased complexity of the drugs themselves, many of which are temperature sensitive and of high value, tells us the service provided by a specialty courier such as Marken satisfies a critical need in the supply chain and the successful completion of each clinical trial. We were very pleased to reaffirm that our strategy aligns well with what our clients and potential clients need most.”
The survey was conducted by an outside firm familiar with the pharma outsourcing market and contains a significant amount of informative data on the industry, the key decision makers and their decision making criteria. A full copy of the survey results can be made available upon request by contacting Marken at email@example.com.
Marken sponsors this type of research along with workshops and round table events all around the globe in order to facilitate information-sharing among the life science and pharma industries. As a thought leader, Marken drives industry collaboration by communicating trends and new ideas so that the industry can learn and grow together.
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies. For more information, visit www.marken.com.